Procalcitonin Test Fails to Reduce Antibiotic Treatment Duration in Hospitalized Children
The procalcitonin biomarker to guide antibiotic treatment in hospitalized children does not shorten intravenous antibiotic duration compared.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Diagnostic Technologies, Sepsis |
The procalcitonin biomarker to guide antibiotic treatment in hospitalized children does not shorten intravenous antibiotic duration compared.
Read MorePosted by Andy Lundin | Jan 6, 2025 | Accreditation |
2024 CAP Laboratory Accreditation Program checklists integrate key CLIA final rule changes, revised personnel requirements, and more.
Read MorePosted by Andy Lundin | Jan 3, 2025 | Molecular Diagnostics |
A novel PCR-based method using CrAss-like phages as microbial source tracking markers can detect human fecal contamination in water.
Read MorePosted by Chris Wolski | Dec 26, 2024 | Pancreatic |
ClearNote Health collaborates with research teams in Southampton, UK, to use their Avantect Pancreatic Cancer Test in a large-scale study.
Read MorePosted by Chris Wolski | Dec 26, 2024 | Company News |
Wildcat DX, LLC has acquired Navis Clinical Laboratories, Inc., enhancing its portfolio of diagnostic lab testing services.
Read More